| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.01.23 | Viridian Therapeutics, Inc: Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating Low Dose VRDN-001 in Patients with Thyroid Eye Disease (TED) | 245 | GlobeNewswire (Europe) | - Significant and rapid improvement in both signs and symptoms of TED after two infusions of 3 mg/kg, generally consistent with prior 10 and 20 mg/kg results - - Among 3 mg/kg VRDN-001 treated patients... ► Artikel lesen | |
| 08.01.23 | CymaBay Therapeutics, Inc.: CymaBay Therapeutics Announces Collaboration with Kaken Pharmaceutical Co., Ltd. to Develop and Commercialize Seladelpar in Japan for Primary Biliary Cholangitis | 246 | GlobeNewswire (Europe) | Advances strategy to partner seladelpar for PBC outside U.S. Brings in approximately $34.0 million upfront payment Japan represents an important market with no currently approved second line treatment... ► Artikel lesen | |
| 08.01.23 | Viracta Therapeutics, Inc.: Viracta Therapeutics Announces First Clinical Response in Epstein-Barr Virus-Positive (EBV+) Solid Tumor Setting and Outlines Key 2023 Clinical Objectives | 218 | GlobeNewswire (Europe) | Partial response (PR) observed in third dose level of the Phase 1b dose escalation study of Nana-val in EBV+ recurrent/metastatic (R/M) nasopharyngeal carcinoma (NPC); enrollment into fourth dose... ► Artikel lesen | |
| 08.01.23 | Amryt Pharma plc: Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc | 430 | GlobeNewswire (Europe) | Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc - Transaction expands Chiesi's rare disease medicine portfolio - All cash acquisition at US$14.50... ► Artikel lesen | |
| 08.01.23 | RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results | 261 | GlobeNewswire (Europe) | ALISO VIEJO, Calif., Jan. 08, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery... ► Artikel lesen | |
| 08.01.23 | Akoya Biosciences, Inc.: Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2022 | 214 | GlobeNewswire (Europe) | MARLBOROUGH, Mass., Jan. 08, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) ("Akoya"), The Spatial Biology Company®, today announced preliminary unaudited revenue for the fourth quarter... ► Artikel lesen | |
| 08.01.23 | Schneider Electric SE: Aims to enhance OT exposure detection capability by identifying misconfigured connected devices Seeks to improve overall security of customers and partners in the OT environment | 824 | GlobeNewswire (Europe) | Schneider Electric, the global leader in the digital transformation of energy management and automation, and BitSight, the leader in detecting and managing cyber risk, today announced a strategic partnership... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 4.125 |
| NVIDIA | 2.755 |
| TUI | 2.165 |
| GAMESTOP | 2.152 |
| BAYER | 1.648 |
| NEL | 1.570 |
| RHEINMETALL | 1.319 |
| BYD | 1.224 |
| DEUTSCHE LUFTHANSA | 1.023 |
| TESLA | 850 |
| VOLKSWAGEN | 750 |
| CARL ZEISS MEDITEC | 731 |
| SUPER MICRO COMPUTER | 671 |
| APPLE | 649 |
| DEFI TECHNOLOGIES | 601 |
| BASF | 593 |
| AIXTRON SE | 582 |
| COMMERZBANK | 571 |
| THYSSENKRUPP | 549 |
| CAVENDISH HYDROGEN | 540 |
| PORSCHE SE | 517 |
| BIONTECH | 470 |
| DEUTSCHE BANK | 452 |
| MERCEDES-BENZ | 450 |
| ALLIANZ | 446 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
